AO
American Oriental Bioengineering, Inc.
AOBI · OTC
$0.01 +0.00% (+$0.00)
Market Cap ₩128.7K
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/E 0.00x
EV/EBITDA 0.35x
P/S 0.00x
Growth
44 /100
Stable EPS growth 56.95%
Rev. growth 1.58%
FCF growth 11.46%
Profitability
73 /100
Strong Gross margin 44.29%
Net margin 34.68%
Op. margin 10.53%
Quality
32 /100
Poor ROIC 2.77%
ROA 10.89%
Asset turnover 0.31x
Debt
86 /100
Low Debt/Equity 0.11x
Current ratio 0.53x
Int. coverage 42.79x
Stability
31 /100
Unstable Beta 0.21x
Rev. volatility 2.86%
EPS volatility 191.40%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AOBI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Shujun Liu
Employees
3,719
Headquarters
Beijing